WHITE CROSSは若手歯科医師の3人に1人が登録する、国内最大級の歯科向け情報サイトです。











臨床応用可能なレンチウイルスベクターを用いた造血幹細胞を標的とした新生児遺伝子治療により、マウスの骨軟化症が改善される | 日本語AI翻訳でPubMed論文検索 | WHITE CROSS 歯科医師向け情報サイト


PubMedの提供する医学論文データベースを日本語で検索できます。AI(Deep Learning)を活用した機械翻訳エンジンにより、精度高く日本語へ翻訳された論文をご参照いただけます。
Hum. Gene Ther..2019 11;30(11):1395-1404. doi: 10.1089/hum.2019.047.Epub 2019-07-03.


Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in Mice.

  • Henrik Löfvall
  • Michael Rothe
  • Axel Schambach
  • Kim Henriksen
  • Johan Richter
  • Ilana Moscatelli
PMID: 31179768 DOI: 10.1089/hum.2019.047.



Infantile malignant osteopetrosis (IMO) is an autosomal recessive disorder characterized by nonfunctional osteoclasts. Approximately 50% of the patients have mutations in the gene, encoding for a subunit of the osteoclast proton pump. Gene therapy represents a potential alternative treatment to allogeneic stem cell transplantation for IMO. The mouse is a model of IMO characterized by a 1,500 bp deletion in the gene, severe osteopetrosis, and a life span of only 3 weeks. Here we show that the osteopetrotic phenotype in mice can be reversed by hematopoietic stem cell-targeted gene therapy with a clinically applicable lentiviral vector expressing a wild-type form of human under the mammalian promoter elongation factor 1α short (EFS-hT). c-kit fetal liver cells transduced with EFS-hT were transplanted into sublethally irradiated mice by temporal vein injection 1 day after birth. A total of 9 of 12 mice survived long term (19-25 weeks) with evidence of tooth eruption, uncharacteristic of mice. Splenocytes were harvested 19-25 weeks after transplantation and differentiated into osteoclasts on bone slices to assess resorption and on plastic to assess TCIRG1 protein expression. Vector-corrected osteoclasts showed human TCIRG1 expression by Western blot. CTX-I release relative to that mediated by -derived osteoclasts increased 8-239-fold. Resorption pits on bone slices were observed for osteoclasts derived from 7/9 surviving transplanted mice. Histopathology of the bones of surviving animals showed varying degrees of rescued phenotype, the majority with almost full correction. The average vector copy number per cell in the bone marrow was 1.8 ± 0.5. Overall, 75% of transplanted mice exhibited long-term survival and marked reversal of the osteopetrotic bone phenotype. These findings represent a significant step toward the clinical application of gene therapy for IMO.